For women, breast cancer is the most commonly diagnosed cancer and the leading cause of women deaths due to cancer. In recent years, increasing long noncoding RNA (lncRNA) has been discovered to be related to tumorigenesis, progression, and prognosis. FOXD3-AS1 is a lncRNA and has been identified as a cancer-promoting gene in glioma. By analysing the FOXD3-AS1 expression in The Cancer Genome Atlas (TCGA) database, we found that FOXD3-AS1 has significantly high expression in breast cancer tumour comparing with the normal tissue. And patients with low FOXD3-AS1 expression had greater survival probability, smaller tumour size, and less distant metastasis. This leads us to peep inquisitively biological function of FOXD3-AS1 in breast cancer. Biological assays demonstrated that silenced FOXD3-AS1 impaired cell proliferation and inhibited cell migration and invasion in breast cancer cell lines (BT549, MDA-MB-231). These results suggest that FOXD3-AS1 could play a potential diagnostics or prognostic biomarker for patients with breast cancer. Significance of the study: We demonstrated that lncRNA FOXD3-AS1 has significantly high expression in breast cancer cell lines comparing with the normal tissue. Besides, our findings suggested that lncRNA FOXD3-AS1 could play a potential diagnostics or prognostic biomarker for patients with breast cancer. KEYWORDS FOXD3-AS1, breast cancer, invasion, lncRNA, migration 1 | INTRODUCTION Breast cancer is the first cause of new cancer diagnoses in women, approximately 30% of all new cases. And breast cancer is the second cause of leading cancer deaths; about 14% of all cancer deaths in women, the first cause is lung and bronchus cancer. From 2005 to 2014, breast cancer incidence has a slight increase. Nonwhite women promote the overwhelming majority of the increase (increases 1.7%per year among Asian and 0.3%-0.4% per year among Hispanic and black). 1,2 The higher diagnosing rate is probably because of the development of medical services and perfection of medical insurance. As the development of medical technology, significant advances have been made in the management of breast cancer. 3,4 But the death rate of breast cancer is still high, and patient outcomes still merit attention.As is known, tumorigenesis is related to the environment, living habits, aging, and so on. 5,6 But the molecular mechanisms of breast tumorigenesis still remain unclear. A lot of studies have discovered many oncogenes and tumour suppressor genes, which are acknowledged to be related to the occurrence of breast cancer. [7][8][9] Long noncoding RNAs as a heterogeneous class of noncoding RNAs, which are longer than 200 nucleotides, have been identified to involve in many human diseases, including tumorigenesis. 10,11 A few long noncoding RNAs (lncRNAs) have been identified as oncogenic or suppressor genes and regulate the progress of breast cancer. 12 lncRNA Yaoyao Guan and Adheesh Bhandari equally contributed to this study.